摘要
目前国内外对于人工髋关节置换后下肢深静脉血栓形成的发病机制与危险因素基本已达成一致意见;应用低分子肝素是目前最常用、效果最可靠的手段;对于低分子肝素的不良反应尚存在一定争论,多数研究认为,除了少量增加置换后出血以外,低分子肝素的应用是安全的。
The pathogenesy and risk factors for deep vein thrombosis following artificial hip replacement have reached a basic agreement at home and abroad. Low molecular weight heparin is the most common and reliable method. However, it is controversial about the adverse reactions of low molecular weight heparin. Most studies demonstrate that the application of low molecular weight heparin is safe besides minimal increase in bleeding after replacement.
出处
《中国组织工程研究与临床康复》
CAS
CSCD
北大核心
2008年第22期4323-4327,共5页
Journal of Clinical Rehabilitative Tissue Engineering Research
